International Cannabis Weekly: 325

‘DIFFICULTY IN THE DETAILS’ SEES GERMANY’S CANNABIS ACT DELAYED

Germany’s landmark Cannabis Act (CanG), which would establish an adult-use cannabis framework in Europe’s most populous country, has been pushed back by a number of months.

READ MORE  »

UKRAINE LAWMAKERS POISED TO PASS MEDICAL CANNABIS LEGALISATION BILL

READ MORE »

MARYLAND OPENS FIRST CANNABIS BUSINESS LICENCE APPLICATIONS

READ MORE »

• Unveiling the expense of cannabis in Germany: analysing the figures for patients and practitioners.
• What valuable insights can the UK gain from more established medicinal cannabis markets?
• UK’s Phytovista Laboratories celebrates as natural CBD supplement is approved for Informed Choice Certification.
•  MPs call on ministers to deliver clear funding pathway for children with epilepsy to get medical cannabis on the NHS.
• Medical cannabis exports in Portugal on track to break record, however export growth is slowing.
• UK’s Celadon Pharmaceuticals signs new £26 million supply agreement with leading EU medical cannabis company.

READ WEEKLY STOCK REPORT »

• Florida’s Supreme Court considers whether adult-use legalisation bill should be included on 2024 ballot.
• Kentucky approves emergency rule to regulate hemp-derived cannabinoid products.
• New York lawmakers send cannabis tax-cut bills to governor, providing local relief for NYC businesses.
• Michigan cannabis sales dip in October as legal action against retailers gathers pace.
• Florida’s Trulieve Cannabis Corp. announces Q3 financial results with revenue slipping less than expected.
• Seattle’s Nevis Brands Inc. announces licensing agreement and expansion of Major™ brands to Michigan.

PRE ORDER NOW »

• Aurora Cannabis reports double-digit revenue growth and record pre-tax profits in Q2 as EU medical cannabis sales soar.
• Canopy Growth announces financial results for Q2 2024, showing third consecutive quarter of revenue growth.
• Toronto’s Avicanna reports Q3 revenue of C$6.27 million, a 90% increase from the previous quarter.
• Allied Corp. successfully completes another shipment of medical cannabis from Colombia to Australia.
• Toronto’s MediPharm Labs Corp. reports higher Q3 gross margin and moves closer to profitability.
• British Columbia’s IM Cannabis Corp. reports Q3 earnings with C$12.37 million in sales.

REGISTER FOR EARLY BIRD TICKETS »

• Argentina’s first homegrown cannabis oil to be made available in pharmacies before the end of the year.
• Brazilian cannabis museum, located in the city of João Pessoa, Paraíba, opens to exhibitors. 
• City of Porto Seguro, Brazil, approves distribution of cannabis for medicinal purposes.
• Rio de Janeiro implements free distribution programme for cannabis-based medicines.

• Australia’s ECS Botanics launches new range of GMP-certified pastilles and vapes.
• AU$2.5 million research project seeks to identify hemp varieties that will perform best in Australia’s climate.
• Japan’s Lower House approves legislation to legalise cannabis-based medical products.
• Cannabiz joins forces with Prohibition Partners to bring Oceania Regulatory Report to market.

• Medical cannabis products in Israel expected to be re-divided into a new structure of dosage categories.
• South Africa’s National Assembly (NA) officially approves cannabis for private purposes bill.